Anti-cholesterol drug fights breast cancer
Researchers at Lund University Hospital say traditional drugs to lower cholesterol can be an inexpensive and effective tool in fighting breast cancer.
The discovery follows a clinical trial involving 50 women with breast cancer. In several cases an enzyme treatable by statins, cholesterol-lowering drugs, was found in the tumors.
The researchers believe two out of three women with breast cancer would benefit by a treatment involving statins.
In the hospital’s newsletter, oncologist Signe Borgquist writes “The study shows that we succeeded in introducing the medicine into the breast tumor and that it had the desired effect. The advantage of statins is that they are well-tested, cost-effective, and in principle free of side effects.”